Gastroenterology & Acid Peptic Disorders
Setuda DSR
Rabeprazole Sodium 20mg + Domperidone 30mg SR
Dual-action gastroprokinetic and proton pump inhibitor capsule providing 24-hour suppression of gastric acid alongside sustained upper gastrointestinal motility enhancement.
Standardized Actives
Rabeprazole Sodium IP 20mg (Enteric Coated) + Domperidone IP 30mg (Sustained Release).
Therapeutic Purpose
- Gastroesophageal Reflux Disease (GERD) with acid reflux and regurgitation
- Non-ulcer dyspepsia, epigastric fullness, and delayed gastric emptying
- Duodenal and benign gastric ulceration maintenance
- Healing of erosive or ulcerative GERD refractory to monotherapy
Administration & Care
1 capsule once daily in the morning, taken 30 to 60 minutes before breakfast.
Strip of 10 capsules in moisture-proof Alu-Alu strip. — Store below 25°C in a dry place. Protect from light.
Quality, Safety & Manufacturing Standards
Every batch of Aanav Healthcare formulations is manufactured under strict current Good Manufacturing Practices (cGMP) in licensed facilities in Mumbai, India. We subject all active pharmaceutical ingredients and botanical extracts to multi-stage purity, stability, and assay tests.
- Product Title
- Setuda DSR (Rabeprazole Sodium 20mg + Domperidone 30mg SR)
- Therapeutic Segment
- Gastroenterology & Acid Peptic Disorders — Gastroenterology
- Active Formula
- Rabeprazole Sodium IP 20mg (Enteric Coated) + Domperidone IP 30mg (Sustained Release).
- Dosage & Use
- 1 capsule once daily in the morning, taken 30 to 60 minutes before breakfast.
- Pack Packaging
- Strip of 10 capsules in moisture-proof Alu-Alu strip.
- Storage Guidelines
- Store below 25°C in a dry place. Protect from light.
- Regulatory Compliance
- Schedule H Prescription Drug — cGMP Certified.
